Related Experiment Video

Updated: May 30, 2026

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
13:08

Expansion of Human Peripheral Blood γδ T Cells using Zoledronate

Published on: September 9, 2011

New perspectives on zoledronic acid in breast cancer: potential augmentation of anticancer immune response

Erika Hamilton1, Timothy M Clay, Kimberly L Blackwell

  • 1Department of Medicine/Medical Oncology, Duke University Medical Center, Durham, NC, USA.

Cancer Investigation
|August 17, 2011
PubMed

Insights

Gamma-delta T cells target cancer cells overexpressing phosphoantigens. Zoledronic acid treatment enhances this effect in breast cancer, suggesting a novel anticancer mechanism.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • Gamma-delta T cells recognize phosphoantigens on cancer cells.
  • Nitrogen-containing bisphosphonates, like zoledronic acid, increase phosphoantigen levels in cancer cells.
  • Zoledronic acid exhibits anticancer activity in breast cancer trials.

Purpose of the Study:

  • To investigate the mechanism of zoledronic acid's anticancer activity.
  • To explore the role of gamma-delta T cells in zoledronic acid's efficacy.

Main Methods:

  • Preclinical study involving zoledronic acid and gamma-delta T cells.
  • Treatment of estrogen-receptor-positive breast cancer cells with zoledronic acid.
  • Assessment of gamma-delta T cell targeting and killing of treated cancer cells.

Main Results:

  • Gamma-delta T cells effectively targeted zoledronic acid-treated breast cancer cells.
  • Zoledronic acid treatment led to increased phosphoantigen accumulation in cancer cells.
  • Demonstrated selective killing of cancer cells with high phosphoantigen levels.

Conclusions:

  • Gamma-delta T cell activation by phosphoantigens is a potential mechanism for zoledronic acid's anticancer effects.
  • Zoledronic acid may enhance immunotherapy by increasing cancer cell vulnerability to gamma-delta T cells.
  • These findings offer insights into zoledronic acid's role in breast cancer treatment.

More Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...